The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.
The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments on gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.Video from ECR 2019: Alexander Radbruch on gadolinium debate
Feb 28, 2019
Latest in PACS/VNA
MedDream launches latest version of DICOM viewer
August 13, 2025
Rhapsody releases new DICOM system
August 13, 2025
RamSoft and ClinicAid ink expanded agreement
August 6, 2025